专利号:US-9744252-B2 优先权日:2011-08-17 标 题:Compounds for binding to the platelet specific glycoprotein IIb/IIIa and their use for imaging of thrombi 发明人:BERGER MARKUS; KRUGER MARTIN; LOHRKE JESSICA; REINHARDT MICHAEL; SIEBENEICHER HOLGER 权利人:PIRAMAL IMAGING SA 摘要:The present invention relates to novel fluorine containing compounds, methods for their preparation, the intermediates of the synthesis, their use as diagnostic agents, especially for imaging of thrombi. The invention relates to positron emission tomography (PET) agents and associated precursor reagents, and methods for producing such radiolaveled agents for imaging of thrombi in a mammalian body. More particularly, the invention relates to small nonpeptide, high-affinity, specific-binding glycoprotein IIb/IIIa antagonists for imaging of thrombi.
专利号:US-8926945-B2 优先权日:2005-10-07 标题:Compounds comprising a biological target recognizing part, coupled to a signal part capable of complexing gallium 发明人:PORT MARC; COROT CLAIRE; GAUTHERET THIERRY 权利人:PORT MARC; COROT CLAIRE; GAUTHERET THIERRY; GUERBET SA 摘要:The invention concerns compounds comprising a biological target recognizing part, coupled to a signal part capable of complexing gallium. The invention also concerns methods for obtaining said compounds, screening methods capable of selecting such compounds for chemical synthesis thereof and their diagnostic applications, in particular in PET, PET/IRM, PET CT imaging.
专利号:US-2013030282-A1 优先权日:2011-07-18 标题:Synthesis and characterization of near ir fluorescent magnetic and non-magnetic albumin nanoparticles for biomedical applications 发明人:MARGEL SHLOMO; COHEN SARIT; SALKMON ENAV COREM; PELLACH MICHAL 权利人:UNIV BAR ILAN; MARGEL SHLOMO; COHEN SARIT; SALKMON ENAV COREM; PELLACH MICHAL 摘要:The present invention discloses Near Infrared (NIR) fluorescent albumin nanoparticles having a structure selected from a core structure or a core-shell structure. Also disclosed are a process of preparing these NIR fluorescent albumin nanoparticles, and a method of in vivo detection of pathologies, in particular cancer pathology, by using administering these NIR fluorescent albumin nanoparticles to a patient.
专利号:US-2022411407-A1 优先权日:2019-11-15 标题:Aryl aminopyrimidines as dual mertk and tyro3 inhibitors and methods thereof 发明人:WANG XIAODONG; ZHOU YUBAI; DING RANSHENG; KONG DEYU; FRYE STEPHEN 权利人:UNIV NORTH CAROLINA CHAPEL HILL 摘要:Aminopyrimidine containing compounds that inhibit both Mer tyrosine kinase (MerTK) activity and Tyro3 kinase activity are disclosed herein. Additionally disclosed are methods of synthesis and use of the aminopyrimidine containing compounds as anti-cancer agents, immunostimulatory and immunomodulatory agents, anti-platelet agents, anti-infective agents, and as adjunctive agents.
专利号:CN-1740158-A 优先权日:2005-09-26 标题:Synthesis process of Tilofiban hydrochloride intermediate
1: Bano S, Ahmed FW, Saeed A, Nawazish A, Haris M, Mansoor A, Jamali AG, Ahmed R, Khan SH, Akram N, Salahuddin Z, Umar M, Abufatima IO. Efficacy and safety of Tirofiban following intravenous thrombolysis: a systematic review and meta- analysis of randomized controlled trials. BMC Neurol. 2026 Apr 17. doi: 10.1186/s12883-026-04892-8. Epub ahead of print. 105(16):e48070. doi: 10.1097/MD.0000000000048070. 4: Lu X, Cao L, Zeng L, Zhang L. Tirofiban combined with aspirin for branch atheromatous disease: a propensity score-matched study. Front Neurol. 2026 Apr 1;17:1802990. doi: 10.3389/fneur.2026.1802990. 5: A A, P A, Subramani S, V R. Comment on "Leukoaraiosis in patients with tirofiban before endovascular thrombectomy: A post hoc analysis of a multicentre randomized clinical trial". J Formos Med Assoc. 2026 Apr